Executive summary Acting now on dementia prevention, intervention, and care will vastly
improve living and dying for individuals with dementia and their families, and in doing so …

Imaging has played a variety of roles in the study of Alzheimer disease (AD) over the past
four decades. Initially, computed tomography (CT) and then magnetic resonance imaging …

Alzheimer's disease (AD) is a progressive neurodegenerative disease that often grows in
middle-aged and elderly people with the gradual loss of cognitive ability. Presently, there is …

Structural imaging based on magnetic resonance is an integral part of the clinical
assessment of patients with suspected Alzheimer dementia. Prospective data on the natural …

Alzheimer's disease is a progressive neurodegenerative disease that typically manifests
clinically as an isolated amnestic deficit that progresses to a characteristic dementia …

Alzheimer's disease is the most common form of dementia and the most common
neurodegenerative disease. It manifests as a decline in short-term memory and cognition …

Background Mild cognitive impairment (MCI) due to Alzheimer's disease is the symptomatic
predementia phase of Alzheimer's disease dementia, characterised by cognitive and …

Background: Probiotics have been reported to ameliorate cognitive impairment. Objective:
We investigated the effect of the probiotic strain Bifidobacterium breve MCC1274 (A1) in …

Mild Alzheimer's disease (AD) is often difficult to differentiate from mild cognitive impairment
(MCI) or non-AD dementias. A multitude of diagnostic biomarkers and advanced imaging …

Automatic segmentation of brain sub regions such as White Matter (GM), Corpus Callosum
(CC), Grey Matter (WM) and Hippocampus (HC) is a challenging task due to the variations in …